Kidney Stone Management Devices Market to Reach USD 2,505.11 Million by 2030 | CAGR of 4.8%
Category : Medical Devices | Published Date : Nov 2024 | Type : Press Release
Kidney Stone Management Devices Market Scope & Overview:
In the newly published report, Consegic Business Intelligence states that the Kidney Stone Management Devices Market size was valued at USD 1,724.51 million in 2022 and is projected to grow at a CAGR of 4.8%, reaching USD 2,505.11 million by 2030. Kidney stone management devices encompass a range of advanced tools, including lithotripters, stone retrieval devices, and urinary stents, designed to diagnose, treat, and manage kidney stones effectively. These devices enable minimally invasive procedures, offering benefits such as reduced patient discomfort, shorter recovery times, and enhanced procedural success rates.
The report comprises the Kidney Stone Management Devices Market Share, Size & Industry Analysis, based on Stone Type (Calcium Oxalate, Uric Acid, Struvite, Cystine), Product Type (Lithotripters, Stone Retrieval Devices, Urinary Stents, Others), Treatment (Shock Wave Lithotripsy (SWL), Ureteroscopy (URS), Percutaneous Nephrolithotomy (PNL), Others), End-User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Others), and Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), and Forecast, 2023-2030.
The report contains detailed information on Kidney Stone Management Devices Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profiles, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraints or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
Segmental Analysis :
Based on stone type, the market is segmented into Calcium Oxalate, Uric Acid, Struvite, and Cystine.
- The calcium oxalate segment accounted for the largest market share in 2022, driven by its high prevalence as the most common type of kidney stone caused by dietary and hydration factors.
- The uric acid segment is projected to grow at the fastest rate, fueled by rising cases of metabolic syndromes and dietary habits contributing to uric acid stone formation.
Based on product type, the market is categorized into Lithotripters, Stone Retrieval Devices, Urinary Stents, and Others.
- The lithotripters segment dominated the market in 2022, attributed to technological advancements and their widespread use in non-invasive stone fragmentation.
- The stone retrieval devices segment is expected to register the fastest growth, supported by their efficiency and ease of use in kidney stone extraction procedures.
Based on treatment, the market is segmented into Shock Wave Lithotripsy (SWL), Ureteroscopy (URS), Percutaneous Nephrolithotomy (PNL), and Others.
- The SWL segment held the largest market share in 2022, driven by its non-invasive nature and high success rates for treating kidney stones without surgical incisions.
- The URS segment is anticipated to grow at the highest CAGR, supported by its precision in treating stones located throughout the urinary tract.
Based on end-user, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgery Centers, and Others.
- The hospitals segment accounted for the largest revenue share of 43.25% in 2022, attributed to the availability of advanced infrastructure and specialized healthcare professionals for kidney stone treatments.
- The specialty clinics segment is projected to grow at the fastest rate, supported by dedicated urological care and advanced equipment for minimally invasive procedures.
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.
- North America: Held the largest market share in 2022, valued at USD 606.16 million, driven by advanced healthcare infrastructure and a high prevalence of kidney stone diseases.
- Asia-Pacific: Expected to grow at the fastest CAGR of 5.3% during the forecast period, fueled by rising healthcare awareness, increasing disposable incomes, and a large patient base.
| Report Attributes | Report Details |
| Study Timeline | 2018-2031 |
| Market Size in 2031 | USD 2,505.11 Million |
| CAGR (2024-2031) | 4.8% |
| Stone Type | Calcium Oxalate, Uric Acid, Struvite, Cystine |
| Product Type | Lithotripters, Stone Retrieval Devices, Urinary Stents, Others |
| Treatment | Shock Wave Lithotripsy (SWL), Ureteroscopy (URS), Percutaneous Nephrolithotomy (PNL), Others |
| End-User | Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape encompasses major innovators, aftermarket service providers, industry giants, and niche players, all of which are thoroughly examined by Consegic Business Intelligence in terms of their strengths, weaknesses, and value-addition potential. This report includes detailed profiles of key players, market share analysis, mergers and acquisitions, resulting market fragmentation, and emerging partnership trends and dynamics.
List of prominent players in the Kidney Stone Management Devices Industry:
- Boston Scientific Corporation
- Becton, Dickinson and Company
- Olympus
- STORZ MEDICAL AG
- Coloplast Corp
- DirexGroup
- EDAP TMS
- Inceler Medikal Co. Ltd.
- Dornier MedTech
- Cook Medical
Recent Industry Developments :
- March 2021: Boston Scientific announced its acquisition of Lumenis LTD to expand its urology laser portfolio in the U.S. and Japan.
- June 2020: Olympus launched the Soltive Laser System, featuring thulium fiber laser technology for stone lithotripsy and soft tissue applications.
